Sichuan Shuangma (000935.SZ) holding subsidiary Hubei Jianxiang passed the on-site inspection by the US FDA.

The Smart Finance APP news reported that Sichuan Shuangma (000935.SZ) announced that its controlling subsidiary, Hubei Jianxiang Biopharmaceutical Co., Ltd. (referred to as "Hubei Jianxiang"), has received an on-site inspection report from the US FDA. According to the inspection report, Hubei Jianxiang's quality and production system meet the standards of the US FDA and passed the on-site inspection by the US FDA.